Inhalation of Nitrous Oxide Completed Phase 3 Trials for Fentanyl (DB00813)

IndicationStatusPhase
DBCOND0060957 (Inhalation of Nitrous Oxide)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02533908Combination of Nitrous Oxide 70% With Fentanyl Intranasal for Procedural Analgosedation in ChildrenTreatment